Skip to content

  • INVESTORS
    • PRESENTATION
MY ACCOUNT
SCHEDULE A TEST
CALL 800-522-7424
Psychemedics
  • ABOUT
  • HAIR TESTING
    • The Science Behind Hair Drug Testing
    • Words of Warning
    • 5-Panel Drug Test
      • Amphetamines
      • Cocaine
      • Marijuana
      • Opiates
      • PCP Hair Drug Test
    • Fentanyl Hair Drug Testing
    • Adderall Testing
    • Benzodiazepines Testing
    • Synthetic Cannabinoids
    • Hair Alcohol Testing (EtG)
    • At Home Drug Testing Kit – PDT 90
    • Hair Test FAQs
  • INDUSTRIES
    • Education/School Drug Testing
    • Transportation
    • Services
    • Manufacturing
    • Oil and Gas
    • Law Enforcement
  • WHY PSYCHEMEDICS
  • RESOURCES
    • Blogs
    • White Papers
    • Press Releases
    • For Our Clients
    • Case Studies
    • Representative Cases
  • COLLECTORS
  • CONTACT

Psychemedics Corporation Announces 2014 Record First Quarter Revenues

February 4, 2020April 29, 2014 by Psychemedics

Download the PDF file Psychemedics Corporation Announces Record First Quarter Revenues.
Categories Press Releases
Heroin Trends Rising
Drug Testing for all Students to Begin at 3 Local High Schools

Recent Posts

  • Substance Abuse Trends to Watch in the Workforce This Year
  • How Fentanyl Awareness Programs Can Save Lives on Campus
  • Psychemedics Corporation Announces Reverse and Forward Stock Split
  • Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders
  • The Future of Drug Testing in Education: Key Insights from the 2024 Psychemedics Education Insights Report

Categories

  • Blog Posts
  • Corporate
  • Drug News
  • Fentanyl
  • Healthcare
  • News
  • Newsletters
  • Press Releases
  • Schools
  • Uncategorized
  • Webinars
CORPORATE HEADQUARTERS
5220 Spring Valley Road, Ste 230
Dallas, TX 75254
United States
(800) 522-7424

PSYCHEMEDICS

Home

Hair Testing

Industries

Collectors

Call 800-522-7424

© Copyright 2024 – Psychemedics Corporation
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to the application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the Investor Relations section in order to receive the most current information made available by Psychemedics Corporation.

© 2025 Psychemedics • Built with GeneratePress